LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Laura Wright, LLL Leader" <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Fri, 16 Aug 2002 17:38:24 -0400
Content-Type:
text/plain
Parts/Attachments:
text/plain (38 lines)
Is it any wonder that we have not had much success gaining financial help from the Bill and Melanie Gates Foundation?
***************************************************************

WASHINGTON (AP) - Microsoft Corp. Chairman Bill Gates' investment vehicle, Cascade Investment LLC, and the Bill & Melinda Gates Foundation, continued its recent acquisition of stocks in the medical industry, according to a regulatory filing Wednesday.
In terms of number of shares purchased, the three largest additions to existing stakes in the second quarter were all in pharmaceutical companies.

Gates bought another 2,589,000 shares of Eli Lilly & Co., raising his holdings to 2,775,000 shares worth $154.5 million on June 30.

He also acquired an additional 1,339,000 shares of Merck & Co., bringing his stake to 2,698,000 shares valued at $136.6 million, as well as 1,202,000 shares of Pfizer Inc. for holdings of 2,242,000 shares worth $78.5 million.

Gates added to his holdings in other medical companies during the second quarter as well, buying 293,000 shares of Abbott Laboratories, 335,000 shares of Bristol-Myers Squibb Co., 328,000 shares of Icos Corp., 600,000 shares of Johnson & Johnson, 256,000 shares of Pharmacia Corp., 274,000 shares of Schering-Plough Corp. and 251,000 shares of Wyeth.

On June 30, Gates owned 554,000 shares of Abbott Labs worth $20.9 million, 660,000 shares of Bristol-Myers valued at just under $17 million, 5,359,501 shares of Icos worth $90.9 million, 1,090,000 Johnson & Johnson shares valued at just under $57 million, 466,000 Pharmacia shares worth $17.5 million, 514,000 shares of Schering-Plough worth $12.6 million and 476,000 Wyeth shares valued at $24.4 million.

Outside the medical product area, Gates' largest addition to an existing stake in the second quarter was the purchase of 930,000 S&P Depositary Receipts, or SPDRs.

On June 30, Gates owned 1,430,000 of these securities valued at $141.5 million.

The firm opened stakes in three companies during the second quarter: 425,000 shares in Cardinal Health Inc. valued at $26.1 million; 455,700 shares of Fisher Communications Inc. worth $26.8 million; and 1 million shares in Home Depot valued at $36.7 million.

Cardinal Health provides products and services to health-care providers and manufacturers. Fisher Communications is a communications and media company. Home Depot is a home improvement retailer.

According to the filing, Gates didn't make any sales during the second quarter.

08/14/02 18:13 EDT

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2